HOME Research Insight Carl Zeiss AG and Nikon Instruments Dominate the Global Live Cell Imaging Market

Carl Zeiss AG and Nikon Instruments Dominate the Global Live Cell Imaging Market

A number of key players are competing against each other in order to expand their existing customer base in the live cell imaging market. The top three players accounted for ~60% of the total live cell imaging market in 2014. These key players include Carl Zeiss AG (Germany), Nikon Instruments (Japan), and Leica Microsystems (Germany).

Carl Zeiss is the leading player in the equipment market for live cell imaging. The company specializes in optics and optoelectronics. The company invested $135.4 Million on R&D in 2014, as compared to that of $128 Million in 2013, to strengthen its product portfolio. Through its microscopy segment, Zeiss offers equipment such as LSM 880, Axio Observer, Cell Observer SD, Laser TRIF 3, Lightsheet Z.1, Cell observer, ZEN, Colibri.2, and Axio Examiner. The company also provides repair, maintenance, and upgrade services, as well as Zeiss microscopy labs and training and education services. The company has strengthened its position in the market through the adoption of organic growth strategies such as new product launches and agreements.

Nikon Instruments is another leading player in the equipment market for live cell imaging. The company through its microscopy segments offers instruments for a wide range of applications such as developmental biology, cell signaling, and cell culture and maintenance. The company strengthened its position in the market by launching new products. For instance, the company launched Ti-LAPP System; three multiphoton systems A1, MP+, and A1R MP+; and high-content microscope system in the last three years. Additionally, the company partnered with various companies to expand its product offerings and to strengthen its distribution networks.

Some of the major strategies adopted by players in the live cell imaging market include new product launches; agreements, partnerships, and collaborations; acquisitions; and expansions. New product launches was the major growth strategy implemented by the live cell imaging companies. This strategy accounted for a share of over 50.6% of all the strategies adopted by players to widen and strengthen their product portfolios. The key players that adopted this strategy are Becton, Dickinson and Company (U.S.), Carl Zeiss AG (Germany), Leica Microsystems (Germany), Nikon Corporation (Japan), Molecular Devices, LCC (U.S.), PerkinElmer, Inc. (U.S.), Merck Millipore (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Essen Biosciences (U.S.), Andor Technologies (U.K.), Hamamastu Photonics (Japan), and ibidi GmbH (Germany).

Related Reports:

Live Cell Imaging Market by Product (Equipment, Consumables, Software), by Technology (Fluorescence Recovery after Photobleaching, High-Content Screening), by Application (Cell Biology, Stem Cells, Drug Discovery) - Analysis & Global Forecast to 2019

Mr. Rohan
North - Dominion Plaza,
17304 Preston Road,
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support

US : 1-888-600-6441

Search reports